Bruker (BRKR) is down -14.5%, or -$5.88 to $34.67.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker’s Q2 results reflect weak academic, biopharma demand, says Stifel
- Bruker reports preliminary Q2 EPS 32c-34c, consensus 43c
- Bruker price target lowered to $50 from $61 at BofA
- NIH directs staff not to end any extra research projects for now, NY Times says
- Bruker’s Growth Potential Driven by Innovations and Strategic Cost Management